Close Menu

NEW YORK (GenomeWeb) – The Laboratory Corporation of America's Covance drug development business plans to offer single-cell DNA analysis services to its biopharmaceutical customers on Mission Bio's single-cell platform, Tapestri. In addition, the companies plan to evaluate the platform for the development of companion diagnostics, Mission Bio said on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.